Selected Skin Products for Cancer Patients: A Product Satisfaction Survey
The primary objective of this study is to evaluate product satisfaction of the following
test articles A, B, and C: Lindi Skin soothing balm (product A), Lindi Skin face serum
(product B), and Lindi Skin face wash (product C). This will be done by measuring change in
Skindex-16 questionnaire at two time points (baseline and follow-up visits) and by
evaluating responses to the investigator administered product satisfaction survey.
The secondary objective of this study is to see if there is any correlation between product
satisfaction and grade of skin toxicity based on NCI-CTCAE v.3.0 scale.
Participants in this study will be patients seen at the Northwestern University SERIES
clinic or Lurie Cancer Center who are receiving chemotherapeutic and or radiation
treatments. Subjects who choose to participate complete a Skindex16 questionnaire, and will
after consenting to participate, be given all three test articles A, B, and C to use daily
for one month. (These test articles are currently marketed products classified by the FDA as
At the return visit, 1 month after baseline visit, the participant will be asked to return
the test articles and complete an investigator administered product satisfaction
questionnaire for each test article used. 100 participants will be surveyed. Subjects will
be telephoned to check for product compliance after 1 week and 2 week intervals.
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Product Satisfaction of the Following Test Articles A, B, and C: Lindi Skin Soothing Balm (Product A), Lindi Skin Face Serum (Product B), and Lindi Skin Face Wash (Product C)
one month of use
Mario E Lacouture, MD
United States: Institutional Review Board
|Northwestern University Department of Dermatology||Chicago, Illinois 60611|